Navigation Links
Massive reanalysis of genome data solves case of the lethal genes
Date:10/18/2007

WALNUT CREEK, CA It is better to be looked over than overlooked, Mae West supposedly said. These are words of wisdom for genome data-miners of today. Data that goes unnoticed, despite its widespread availability, can reveal extraordinary insights to the discerning eye. Such is the case of a systematic analysis by the U.S. Department of Energy Joint Genome Institute (DOE JGI) of the massive backlog of microbial genome sequences from the public databases. The survey identified genes that kill the bacteria employed in the sequencing process and throw a microbial wrench in the works. It also offers a possible strategy for the discovery of new antibiotics. These findings are published in the Oct. 19 edition of the journal Science.

In nature, promiscuous microbes share genetic information so readily that using genes to infer their species position on the evolutionary tree of life was thought to be futile. Now, researchers at DOE JGI have characterized barriers to this gene transfer by identifying genes that kill the recipient bacterium upon transfer, regardless of the type of bacterial donor. These lethal genes also provide better reference points for building phylogenic treesthe means to verify evolutionary relationships between organisms.

At DOE JGI, we are responsible for producing and making publicly available genomes from hundreds of different microbes, most of which are relevant to advancing the frontiers of bioenergy, carbon cycling, and bioremediation, said Eddy Rubin, DOE JGI Director. We realized that sequencing a genome is like conducting a massive experiment in gene transfer. By checking which genes could not be sequenced, we discovered barriers to transfer.

The industrial-scale shotgun DNA sequencing strategy typically involves sheering the organisms DNA into manageable fragments, and then inserting these fragments into a disarmed strain of E. coli, which is used as an enrichment cultureto grow up vast amounts of the
'/>"/>

Contact: David Gilbert
degilbert@lbl.gov
925-296-5643
DOE/Joint Genome Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. UW Condor project is a piece of CERNs massive grid computer
2. New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes
3. WHOLE GENOME SEQUENCING
4. Protocol for GenomePlex Whole Genome Amplification from Buccal Swab
5. Protocol for GenomePlex Whole Genome Amplification from Blood Card
6. Protocol for GenomePlex Whole Genome Amplification from Plant
7. Protocol for GenomePlex Whole Genome Amplification from Soil
8. Protocol for GenomePlex Whole Genome Amplification from Whole Blood
9. Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue
10. Bacterial Whole Genome Array Analysis
11. Cenix-Designed siRNAs for 95% of Human and Mouse Genomes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ay announced a collaborative research agreement wi...luating EpiVax’s proprietary Tregitope techn...immune responses to certain drugs. In the course o...tope technology will be evaluated for its effect o... (Vocus) December 2, 2009 ...
(Date:12/1/2009)...wire-FirstCall/ -- Palatin Technologies, Inc. (NYS...t and Trademark Office has issued U.S. Patent No. ...tructs." The claims in the issued patent cover a ...c peptide receptor A (NPRA), including PL-3994, Pa...Our natriuretic compounds, including PL-3994, addr...
(Date:12/1/2009)...ifornia and AMSTERDAM, December 1 ,...stics, announced today that,Palmetto GBA, Californ...d,coding guidelines for the company,s MammaPrint t...ncer recurrence test, which has been reimbursed by... United States can now submit claims for the,Mamma...
(Date:12/1/2009).... 1 /PRNewswire-Asia-FirstCall/ -- China Sky One M...any") (Nasdaq: CSKI ), a leading,fully integrated...ver-the-counter drugs in the People,s Republic of ...s engaged Guangdong Mediacy Kind Medical Devices,I...clusive sales agent for the,Company,s AMI Diagnost...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3
...el Discussion on Technologies That Will Change the...Each Other , , PISCATAWAY, N.J., March 10 IEEE, ..., today spotlighted seven technologies it believes...humans interact with machines, the world and each ... 10 March 2009 at the New Yorker Hotel in New York...
...AI ratio now available with VAP Cholesterol Test a...10 Atherotech, Inc., a cardio-diagnostic company,...(apoAI) to its VAP(R) Cholesterol Test. The VAP (V...esterol test that routinely reports apoAI, apoB, a...of this new marker, the VAP Test now reports apoAI...
...if., March 10 Frost & Sullivan recognizes Bio...p; Sullivan Award for Growth Strategy Leadership o...sis of the most significant drug-discovery innovat... leaders. BioTrove, a privately held company speci...nt technologies, has gained significant traction w...
Other Biology Technology:IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 2IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 3IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 4Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test 2Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 2Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 4
(Date:11/30/2009)... , , CLEMSON Clemson University researchers Ron ...Environmental Protection Agency grant to study the...ations located deep below the earth,s surface. , ... fuels believed to be the leading cause of global ... most promising alternatives for reducing emission...
(Date:11/30/2009)... , This release is available in German . ,... Collaborative Research Centres as of 1 January 20...t Grants Committee in Bonn. The new centres will i...132 million. In addition, 20 percent overhead fund...ach project. The centres, research topics range fr...
(Date:11/30/2009)... , The Editors of The Journal of Experimental Bi...in from Centre National de la Recherche Scientifiq...s is the winner of this year,s JEB Outstanding P...f an outstanding achievement and is intended to en...e JEB Editor-in-Chief, and adds that ,we truly a...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10BIO key 28R 29 International Exhibiting at AABB TXPO 10528 1BIO key 28R 29 International Exhibiting at AABB TXPO 10528 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 1Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 3
... It is well known that animals use song as a way o...t gibbons have developed an unusual way of scaring...ogists at the University of St Andrews discovered ...que song as a natural defence to predators. Liter...se the song not just to warn their own group membe...
... Amsterdam, 21 September, 2006 - Elsevier is delig...ement to the journal Vaccine: HPV Vaccines and Scr...special monograph provides a comprehensive and inv... health educators, policy decision makers, industr...he arrival of the Human Papillomavirus (HPV) vacci...
... Before you request a paternity test, spend a few ... just give you the answer you,re looking for. Acc...versity of Tromso, Norway, the human eye color ref...attern of inheritance. Their studies, published t...y and Sociobiology, show that blue-eyed men find b...
Other Biology News:Singing for survival 2Singing for survival 3Blue eyes -- A clue to paternity 2
...s ideal for developing single and multi-analyte as...m contains the new, improved, and user friendly IS...n specific templates for commercial or home-made m...phing and data regression capabilities; the intern...
GeneSwitch-CHO Cell Line from Invitrogen
...ancements when used as directed, The AmpliCruz ...gned to amplify the desired signal detected by Wes... proteins with low expression., Membrane Enhanc... to blocking the membrane; 1x solution; 250 ml, ...
Silencer CellReady siRNA Transfection Optimization Kit from Ambion
Biology Products: